Sponsors (3)
Official title: Set forth requirements for the regulation by the Food and Drug Administration of nitrous oxide products, and for other purposes.
Introduced July 15, 2026 by Ronald Lee Wyden · Last progress July 15, 2026
The bill prioritizes reducing youth nitrous‑oxide misuse and building prevention/oversight capacity, but does so at the cost of increased regulatory and compliance burdens for businesses and agencies, potential privacy impacts for purchasers, uncertain federal spending, and possible access impacts for legitimate medical and food‑service uses.
Children and young adults will face reduced access to nitrous oxide and fewer youth‑appealing products because of age verification, sales/delivery restrictions, bans on flavored/child‑friendly packaging, and required warning labels.
Communities, schools, and health systems will get funding, prevention education, and clinical training (grants to local nonprofits/schools, targeted education campaigns, and emergency/poison‑control training) that build local capacity to prevent and respond to nitrous‑oxide misuse.
Federal regulation and monitoring will become clearer and more actionable because FDA is required to issue regulations within a year and agencies must collect annual enforcement and health‑outcome data to guide targeted interventions.
Small businesses and retailers will face new compliance costs (ID checks, locked storage, restricted displays, recordkeeping), administrative burdens, and exposure to civil penalties (statutory fines up to $100,000 per proceeding).
Patients and health providers who rely on nitrous oxide for legitimate medical or food‑service uses may face reduced availability, product restrictions (e.g., 8‑gram limits, flavor bans), or higher costs.
Taxpayers face open‑ended federal spending risks because the bill authorizes multi‑year funding and grant programs without specified dollar caps or offsets, potentially increasing federal outlays.
Based on analysis of 5 sections of legislative text.
Directs FDA to regulate nitrous oxide products (banning flavors, requiring warning labels, limiting cartridge size), raises purchase age to 21, creates prevention grants, and mandates rulemaking and reporting.
Establishes new FDA regulatory requirements for products containing nitrous oxide to reduce recreational inhalation misuse while preserving legitimate medical, industrial, and food uses. The bill bans flavored nitrous oxide products, limits grams per food-use cartridge, requires prominent warning labels and restrictions on marketing and display, raises the minimum purchase age to 21, and directs rulemaking, enforcement reporting, and grant funding for community prevention efforts. Requires FDA to issue regulations within one year, creates a grant program for education and training to reduce nitrous oxide misuse, mandates annual reporting to Congress on enforcement and public health outcomes, and authorizes unspecified appropriations for FY2027–FY2036 to implement the law.